Loading…
Tuesday, June 20 • 8:00am - 9:30am
#202: People Will Talk: Gathering Insights from Digital Listening

Sign up or log in to save this to your schedule and see who's attending!

Tweet Share
Feedback form is now closed.
Component Type: Forum
Level: Intermediate
CE: ACPE 1.50 Knowledge UAN: 0286-0000-17-566-L04-P; CME 1.50; IACET 1.50; RN 1.50

There is growing interest from global stakeholders — biopharma, regulators, and patients — to analyze digital health information either posted online by patients or captured by pharma through patient/HCP requests. This information represents a large repository of safety and patient experience insights that could supplement data from existing sources. Panelists in this DIAmond session will address how digital health information can be analyzed to support medical affairs, pharmacovigilance and commercialization efforts. Topics addressed include an overview of techniques, use cases, compliance with regulatory guidelines, and patient privacy.

Learning Objectives

Describe the challenges of using social media data to supplement postmarketing safety data; Discuss the impact of social media data on compliance with regulatory guidelines.

Chair

Lorrie Schifano, PharmD

Speaker

Current Techniques for Analyzing Text That Can be Used in Medical Affairs, Benefit-Risk Assessment, and the Voice of the Customer
Jeffery Lanier Painter, JR, JD, MS

Digital Listening Throughout a Product's Life Cycle
Chi Bahk, MS

Current Parameters for Collecting/Utilizing This Data Compliantly
Phil Tregunno

Panelist
Gerald J. Dal Pan


Moderators
avatar for Lorrie Schifano

Lorrie Schifano

Director, Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline
Lorrie is Director, Safety Evaluation and Risk Management at GSK. She has more than 16 years experience in the pharmaceutical industry. Dr. Schifano obtained a B.S. in Pharmacy at Duquesne University in Pittsburgh, PA and her Pharm.D. at University of North Carolina, Chapel Hill... Read More →

Speakers
avatar for Chi Bahk

Chi Bahk

Business Operations Lead, Epidemico, Booz Allen Hamilton
Chi is a public health professional with expertise in utilizing non-traditional data sources such as online news and social media for health vigilance, especially in the areas of disease monitoring and patient understanding. She's worked as part of academia, tech start-up, and large... Read More →
avatar for Jeffery Painter

Jeffery Painter

Chief Executive Officer/Founder, Jivecast
Jeffery Painter is the CEO and founder of JiveCast, a firm specializing in building analytics tools for a broad range of industries. While at GSK, Jeff was Director of Analytics in Medical Affairs where he led a data science team using text analytics to better understand the voice... Read More →
avatar for Gerald Dal Pan

Gerald Dal Pan

Director, Office of Surveillance and Epidemiology, FDA
Gerald J. Dal Pan, MD, MHS, is Director of the Office of Surveillance & Epidemiology in FDA’s Center for Drug Evaluation and Research, where he oversees adverse event surveillance and analysis, pharmacoepidemiology, risk management, and medication error prevention. A member of the... Read More →
avatar for Phil TREGUNNO

Phil TREGUNNO

Group Manager, Vigilance, Intelligence and Research Group, Medicines and Healthcare products Regulatory Agency (MHRA)
Phil is a Unit Manager within MHRA's Vigilance Intelligence and Research Group (VIRG) and has over thirteen years of experience working in pharmacovigilance. For the past eight years he has been responsible for leading and developing the Signal Management function, including systems... Read More →

Tuesday June 20, 2017 8:00am - 9:30am
S100c McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  12: DIAmond, Forum
  • format json
  • Featured Topics Clinical Operations,Statistics,Quality-GXP,Patient Centric ,Global Regulatory,Data Management,Real World Evidence,StudentProgramming
  • Credit Type ACPE, CME, IACET, RN
  • Tags Forum